ArticleMethods in molecular biology (Clifton, N.J.)2026
Cryopreservation of Ovarian Cortex Tissue.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian tissue cryopreservation (OTC) is applied as a fertility preservation option for women and girls who are at risk of losing ovarian function due to medical treatments with gonadotoxic side effects, such as chemotherapy or radiotherapy. Especially in prepubertal girls, it is the only option for fertility preservation. Two modes of OTC are practiced: Vitrification and slow freezing. The aim of OTC is the preservation of follicles. Reimplantation of the ovarian tissue provides the patient with a follicle pool, in order to increase the chances of becoming pregnant by serving oocytes and the ovarian hormonal functions. Vitrification of ovarian tissue is a modern cryopreservation technique that rapidly cryopreserves tissue to prevent ice crystal formation, which can damage cells. It is increasingly studied and applied as an alternative to slow freezing. Current meta-analyses indicate that both techniques appear to provide comparable outcomes. Vitrification provides several advantages, including time and cost reduction due to shorter protocols and the omission of slow freezing equipment. Here, we provide a detailed protocol for ovarian tissue vitrification.
Indexed as
Identifiers
42732513What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.